Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-039023

Chief Scientific Officer sold 33,300 shares at an average $46.54 ($1,549,813)

  • Chief Scientific Officer acquired 33,300 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS HARLAN S · Chief Scientific Officer

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2020-06-23 Exercise or conversion : show line 1 in the form +11,100 $6.32 $70,152 11,779 D
2020-06-23 Sale : show line 2 in the form −1,500 $46.21 $69,315 10,279 D
2020-06-23 Sale : show line 3 in the form −9,600 $46.95 $450,720 679 D
2020-06-24 Exercise or conversion : show line 4 in the form +11,100 $6.32 $70,152 11,779 D
2020-06-24 Sale : show line 5 in the form −8,277 $45.72 $378,424 3,502 D
2020-06-24 Sale : show line 6 in the form −2,823 $46.38 $130,931 679 D
2020-06-25 Exercise or conversion : show line 7 in the form +11,100 $6.32 $70,152 11,779 D
2020-06-25 Sale : show line 8 in the form −700 $45.36 $31,752 11,079 D
2020-06-25 Sale : show line 9 in the form −6,657 $46.84 $311,814 4,422 D
2020-06-25 Sale : show line 10 in the form −3,743 $47.25 $176,857 679 D
Open-market sales · 33,300 sh · avg $46.54 · $1,549,813

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-06-23 Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) −11,100 422,400 D
2020-06-24 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −11,100 411,300 D
2020-06-25 Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) −11,100 400,200 D
Loading xslF345X03/doc4.xml…